Pediatric CNS-isolated hemophagocytic lymphohistiocytosis with brain hemorrhages: a case report.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 29 12 2023
accepted: 29 08 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Hemophagocytic lymphohistiocytosis (HLH) is an inherited syndrome characterized by immune dysregulation. Central nervous system (CNS)-isolated disease is a rare presentation of familial HLH. We present a case of pediatric CNS-isolated HLH with a presentation complicated by unusual hemorrhagic intraparenchymal lesions. A 15-year-old male presented with ataxia and MRI findings of multiple hemorrhagic lesions in his cerebral white matter, brainstem, and cerebellum, suggestive of vasculitis. After failing to improve with steroids and plasmapheresis, and progression to acute neurologic decompensation, new brainstem hemorrhages were noted. Further workup revealed 2 PRF1 mutations, confirming a diagnosis of familial CNS-HLH. He was later found to have a platelet granule defect, explaining his atypical neuroradiologic findings. The patient received treatment per the HLH-1994 protocol and underwent stem cell transplantation. Two years post-transplant, his perforin expression is nearly normal and his neurologic deficits have significantly improved. This case illustrates the variability in presentation of isolated CNS-HLH. Although rare, it is important to include this diagnosis on the differential in patients with CNS hemorrhagic lesions. If initial diagnostic studies remain inconclusive or response to early treatments is poor, CNS-HLH should be considered, as delay in diagnosis and treatment significantly affects morbidity and mortality.

Sections du résumé

BACKGROUND BACKGROUND
Hemophagocytic lymphohistiocytosis (HLH) is an inherited syndrome characterized by immune dysregulation. Central nervous system (CNS)-isolated disease is a rare presentation of familial HLH. We present a case of pediatric CNS-isolated HLH with a presentation complicated by unusual hemorrhagic intraparenchymal lesions.
CASE PRESENTATION METHODS
A 15-year-old male presented with ataxia and MRI findings of multiple hemorrhagic lesions in his cerebral white matter, brainstem, and cerebellum, suggestive of vasculitis. After failing to improve with steroids and plasmapheresis, and progression to acute neurologic decompensation, new brainstem hemorrhages were noted. Further workup revealed 2 PRF1 mutations, confirming a diagnosis of familial CNS-HLH. He was later found to have a platelet granule defect, explaining his atypical neuroradiologic findings. The patient received treatment per the HLH-1994 protocol and underwent stem cell transplantation. Two years post-transplant, his perforin expression is nearly normal and his neurologic deficits have significantly improved.
CONCLUSIONS CONCLUSIONS
This case illustrates the variability in presentation of isolated CNS-HLH. Although rare, it is important to include this diagnosis on the differential in patients with CNS hemorrhagic lesions. If initial diagnostic studies remain inconclusive or response to early treatments is poor, CNS-HLH should be considered, as delay in diagnosis and treatment significantly affects morbidity and mortality.

Identifiants

pubmed: 39434014
doi: 10.1186/s12883-024-03840-8
pii: 10.1186/s12883-024-03840-8
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

404

Informations de copyright

© 2024. The Author(s).

Références

Debinski C, Goergen S, McLean C, et al. Exploring the intersection of Isolated-CNS hemophagocytic lymphohistiocytosis and Pediatric Chronic lymphocytic inflammation with Pontine Perivascular Enhancement responsive to steroids. J Child Neurol. 2021;36(11):935–42. https://doi.org/10.1177/08830738211009654 .
doi: 10.1177/08830738211009654 pubmed: 34056941
Benson LA, Li H, Henderson LA, et al. Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm. 2019;6(3):e560. https://doi.org/10.1212/NXI.0000000000000560 . Published 2019 Apr 8.
doi: 10.1212/NXI.0000000000000560 pubmed: 31044148 pmcid: 6467688
Blincoe A, Heeg M, Campbell PK, et al. Neuroinflammatory Disease as an isolated manifestation of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2020;40(6):901–16. https://doi.org/10.1007/s10875-020-00814-6 .
doi: 10.1007/s10875-020-00814-6 pubmed: 32638196
Li H, Benson LA, Henderson LA, et al. Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Blood Adv. 2019;3(4):503–7. https://doi.org/10.1182/bloodadvances.2018027417 .
doi: 10.1182/bloodadvances.2018027417 pubmed: 30760465 pmcid: 6391665
Malik P, Antonini L, Mannam P, et al. MRI patterns in Pediatric CNS Hemophagocytic Lymphohistiocytosis. AJNR Am J Neuroradiol. 2021;42(11):2077–85. https://doi.org/10.3174/ajnr.A7292 .
doi: 10.3174/ajnr.A7292 pubmed: 34620587 pmcid: 8583278
Riley DS, Barber MS, Kienle GS, AronsonJK, et al. CARE guidelines for case reports: explanation and elaboration document. JClinEpi. 2017;89:218–35. https://doi.org/10.1016/jclinepi.2017.04.026 .
doi: 10.1016/jclinepi.2017.04.026
Chung TW. CNS involvement in hemophagocytic lymphohistiocytosis: CT and MR findings. Korean J Radiol. 2007;8(1):78–81. https://doi.org/10.3348/kjr.2007.8.1.78 .
doi: 10.3348/kjr.2007.8.1.78 pubmed: 17277568 pmcid: 2626691
Tachibana A, Kurokawa R, Capizzano AA, et al. Brain MRI findings of Hemophagocytic Lymphohistiocytosis with a heterozygous PRF1 gene mutation masquerading as CLIPPERS: a Case Report. Cureus. 2023;15(3):e36787. https://doi.org/10.7759/cureus.36787 . Published 2023 Mar 28.
doi: 10.7759/cureus.36787 pubmed: 36998916 pmcid: 10043984
Gokce M, Balta G, Unal S, Oguz K, Cetin M, Gumruk F. Spinal cord involvement in a child with familial hemophagocytic lymphohistiocytosis. J Pediatr Neurosci. 2012;7(3):194–6. https://doi.org/10.4103/1817-1745.106477 .
doi: 10.4103/1817-1745.106477 pubmed: 23560006 pmcid: 3611908

Auteurs

Mauricio Borda (M)

Department of Neurology, Montefiore Medical Center, Bronx, NY, USA. mborda@montefiore.org.

Helen Tian (H)

Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.

Steven Benitez (S)

Department of Radiology, Montefiore Medical Center, Bronx, NY, USA.

Ashley Bonheur (A)

Division of Pediatric Critical Care Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.

Nagma Dalvi (N)

Department of Neurology, Montefiore Medical Center, Bronx, NY, USA.

Ellen Fraint (E)

Division of Pediatric Hematology, Oncology, and Cellular Therapy, Nemours Children's Hospital, Wilmington, Delaware, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH